Today: 9 June 2026
Browse Category

NASDAQ:CBOE 9 November 2025 - 6 June 2026

VIX Fear Gauge Above 30 Puts Wall Street at a Crossroads: Buy Stocks or Brace for More Pain?

VIX Fear Gauge Above 30 Puts Wall Street at a Crossroads: Buy Stocks or Brace for More Pain?

Wall Street opened higher Monday, with the Dow up 116 points, but the VIX stayed elevated at 30.79 after last week’s spike. All three major indexes posted a fifth straight weekly loss Friday, their longest streak in nearly four years. Oil prices rose as Brent topped $116 a barrel amid Middle East tensions. Morgan Stanley downgraded global equities and upgraded cash and U.S. Treasuries, citing persistent uncertainty.
30 March 2026
·
VIX slips below 20 as Trump pulls Greenland tariff threat and Wall Street steadies

VIX slips below 20 as Trump pulls Greenland tariff threat and Wall Street steadies

The VIX fell more than 8% to 18.43 on Wednesday after President Trump said planned tariffs on European imports would be dropped, citing a preliminary deal with NATO over Greenland. U.S. stocks rebounded, with the S&P 500 up about 0.5% in afternoon trading. Tuesday’s tariff threat had sent the VIX to an eight-week high and triggered sharp losses across equities and currencies.
21 January 2026
·
Is the Canadian Stock Market Open on Dec. 25, 2025? TSX Christmas Day Hours, Boxing Day Closure, and What Investors Need to Know

Is the Canadian Stock Market Open on Dec. 25, 2025? TSX Christmas Day Hours, Boxing Day Closure, and What Investors Need to Know

Canadian stock markets, including the TSX, TSXV, TSX Alpha, CSE, and Cboe Canada venues, are closed Thursday, Dec. 25, 2025, for Christmas Day. Markets also close Friday, Dec. 26, for Boxing Day. On Dec. 24, trading ended early, with most venues closing by 1:00 or 1:30 p.m. ET. Regular trading resumes Monday, Dec. 29.
25 December 2025
·····
VIX Today After the Bell: “Fear Gauge” Holds Near 17 as Jobs Data, Yields and Skew Keep Volatility Bid (Dec. 16, 2025)

VIX Today After the Bell: “Fear Gauge” Holds Near 17 as Jobs Data, Yields and Skew Keep Volatility Bid (Dec. 16, 2025)

The Cboe Volatility Index climbed to around 17 by late morning Tuesday, up from Monday’s close, as investors reacted to delayed U.S. macro data and ongoing tech sector volatility. The VIX’s move followed a brief spike in rate-cut expectations after new labor-market figures showed higher unemployment and mixed payrolls. Options markets continued to price in elevated downside protection.
16 December 2025
·
VIX Index Today, December 5, 2025: Wall Street’s Fear Gauge Slides Back Toward Lows as Fed-Cut Hopes Build

VIX Index Today, December 5, 2025: Wall Street’s Fear Gauge Slides Back Toward Lows as Fed-Cut Hopes Build

The Cboe Volatility Index (VIX) closed near 15.6 on December 5, down about 1% from Thursday, marking its lowest levels in months. The index traded in a tight range between 15.55 and 16.18, far below the late November spike above 28. The VIX now sits close to the low end of its 52-week range, reflecting subdued equity market volatility.
5 December 2025
··
VIX Index Today (November 26, 2025): Wall Street’s ‘Fear Gauge’ Falls Back Toward 17 as Stocks Rally

VIX Index Today (November 26, 2025): Wall Street’s ‘Fear Gauge’ Falls Back Toward 17 as Stocks Rally

The VIX fell over 8% to end at 17.0 on Wednesday, capping a 35% drop since last Thursday’s close above 26. U.S. stocks rallied for a third straight session, with the Dow up about 400 points after Tuesday’s 664-point surge. The VIX traded between 16.93 and 18.70, well below last week’s peak near 28.3. Traders increased bets on a December Federal Reserve rate cut.
26 November 2025
·
VOO Stock Today, November 17, 2025: Vanguard S&P 500 ETF Slips as Wall Street Braces for Nvidia and Heavy Data Week

Vanguard ETFs Today (Nov. 18, 2025): Vanguard’s First Stock‑Picking ETFs Debut — VDIG, VUSG, VUSV — as SEC Clears Wider ETF Share‑Class Use

Vanguard launched three actively managed, stock-picking ETFs—VDIG, VUSG, and VUSV—on Cboe BZX Tuesday, marking its first U.S. equity active ETF offerings. All three funds are managed by Wellington and began trading at the opening bell. The SEC approved Dimensional Fund Advisors to add ETF share classes to 13 mutual funds, a first since Vanguard’s patent expired.
18 November 2025
··
US Stock Market Today: 7 Things to Know Before the Opening Bell on November 17, 2025

US Stock Market Today: 7 Things to Know Before the Opening Bell on November 17, 2025

Netflix’s 10-for-1 stock split and the launch of Cboe’s “Magnificent 10” futures headline a busy Monday for Wall Street, as investors digest the aftermath of a record U.S. government shutdown. The S&P 500 slipped 0.05% Friday, while the Dow fell 0.65% and the Nasdaq gained 0.13%. Bitcoin dropped to a six-month low. The Empire State Manufacturing Index and remarks from Fed officials are due.
16 November 2025
····
Ethereum (ETH) Price Today, Nov. 9, 2025: ETH Holds Near $3.39K as ETF Flows Swing and ‘Fusaka’ Upgrade Nears

Ethereum (ETH) Price Today, Nov. 9, 2025: ETH Holds Near $3.39K as ETF Flows Swing and ‘Fusaka’ Upgrade Nears

Ethereum traded near $3,390 on Sunday, down 1.3% over 24 hours, with prices ranging from $3,359 to $3,451. U.S. spot ETH ETFs saw a $46.6 million net outflow on Nov. 7 after modest inflows earlier in the week. Cboe plans to launch “continuous” ether futures on Monday, pending approval. The Ethereum Foundation set Dec. 3 for the Fusaka mainnet upgrade.
9 November 2025
·

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop